Literature DB >> 32113848

The effects of Levothyroxine on the structure and dynamics of DPPC liposome: FTIR and DSC studies.

Abeer Aleskndrany1, Ipek Sahin2.   

Abstract

Levothyroxine (3,5,3',5'-tetraiodothyronine), which is a L-isomer of thyroxine T4 (L-T4), is a synthetic thyroid hormone that is biochemically and physiologically indistinguishable from endogenous T4. It is used as a thyroid hormone replacement drug to treat an underactive thyroid gland. The interaction of L-T4, with zwitterionic dipalmitoyl phosphatidylcholine (DPPC) multilamellar liposomes (MLVs) was studied in the presence (1 mol%, 3 mol%, 6 mol%, 9 mol%, 15 mol%, 24 mol% and 30 mol%) and absence of L-T4 by using two different non-invasive techniques; Fourier Transform Infrared (FTIR) spectroscopy and Differential Scanning Calorimetry (DSC). The results show that L-T4 does perturb the phase transition profile by either decreasing the main transition temperature (Tm) and enthalpy (ΔH) or increasing the width at half height (ΔT½). That means; it changes the physical properties of DPPC bilayers. Addition of L-T4 into pure DPPC liposomes shifts the phase transition to lower temperature, disorder the system in gel phase with opposite effect in liquid-crystalline phase and increases the dynamics of the system in both phases and also causes dehydration of the groups of lipids and the water molecules around.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Differential scanning calorimetry; Dipalmitoyl phosphatidylcholine; Drug-membrane interaction; Fourier transform infrared; Levothyroxine

Year:  2020        PMID: 32113848     DOI: 10.1016/j.bbamem.2020.183245

Source DB:  PubMed          Journal:  Biochim Biophys Acta Biomembr        ISSN: 0005-2736            Impact factor:   3.747


  1 in total

1.  Interaction mechanism of three egg protein derived ACE inhibitory tri-peptides and DPPC membrane using FS, FTIR, and DSC studies.

Authors:  Huizhuo Ji; Wenzhu Zhao; Zhipeng Yu
Journal:  Food Chem X       Date:  2022-06-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.